Translate this page into:
Letter to the Editor
doi:
10.4103/sajc.sajc_63_18
Isolated central nervous system blast crisis in a case of chronic myeloid leukemia on dasatinib
1
Department of Medical Oncology, Healthcare Global Enterprises Hospital, Bengaluru, Karnataka
2
Department of Hematology, Healthcare Global Enterprises Hospital, Bengaluru, Karnataka
*Corresponding author: Dr. P.K. Kiran. drkiranpk265@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Acknowledgment
We would like to thank Dr. Sharitha, Department of Pathology, HCG Hospital, Bengaluru.
References
- Greer JP, Arber DA, Glader B, List AF, Means RT Jr., Paraskevas F, et al. Wintrobe's Clinical Hematology. 13th ed. UK:LWW;2013.
- Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haemotopietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
- Rajappa S, Uppin SG, Raghunadharao D, Rao IS, Surath A. Isolated central nervous system blast crisis in chronic myeloid leukemia. Hematol Oncol 2004;22:179-81.
- Pfeifer H, Wassmann B, Hofmann WK, Komor M, Scheuring U, Brück P, et al. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Clin Cancer Res 2003;9:4674-81.
- Altintas A, Cil T, Kilinc I, Kaplan MA, Ayyildiz O. Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: A case report. J Neurooncol 2007;84:103-5.
- Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, et al. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2008;14:1100-7.
- Papageorgiou SG, Pappa V, Economopoulou C, Tsirigotis P, Konsioti F, Ionnidou ED, et al. Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression. Leuk Res 2010;34:e254-6.
- Frigeri F, Arcamone M, Luciano L, Di Francia R, Pane F, Pinto A, et al. Systemic dasatinib fails to prevent development of central nervous system progression in a patient with BCR-ABL unmutated Philadelphia chromosome-positive leukemia. Blood 2009;113:5028-9.